Results per Page:
Brain trust: HCMV hijacks host chromatin to induce dormant neuronal genes
From the Avgousti Lab, Human Biology Division
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Cytomegalovirus has an activity shift following CAR T-cell therapy
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
CMV breakthrough and resistance to antiviral drug after blood stem cell transplants
From Dr. Danniel Zamora and the Boeckh Group, Vaccine and Infectious Disease Division
Computational kinetic modeling informs on uORF buffering activity
From the Geballe and Subramaniam labs, Human Biology and Basic Sciences Divisions
Modeling of human cytomegalovirus infection dynamics in patients
From the Schiffer lab, Vaccine and Infectious Disease Division
A lasting impression: CMV exposure imprints donor T cell phenotypes
From the Hill Lab, Clinical Research Division
From the freezers, a speedier way to evaluate antiviral drugs
Lookback research showed today’s ‘viral load’ measurements and machine learning quickly mirrored outcomes of older, slower trials
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Infectious Diseases Society to honor Dr. Michael Boeckh
Hutch virus expert to deliver John F. Enders Lecture at Washington, D.C., conference
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Scientists learn how common virus reactivates after transplantation
New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
Rethinking an old viral foe
Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
With approval of new CMV drug for transplant patients, a legacy continues
Tissue samples from a clinical trial conducted decades ago yield new insights and treatments
Adam Geballe elected AAAS Fellow
Hutch virologist honored for revealing key players in molecular ‘arms race’ between viruses and hosts
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements